A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)
18 auth.
G. Gallo,
R. Pietroletti,
E. Novelli,
A. Sturiale,
R. Tutino,
P. Lobascio,
R. Laforgia,
E. Moggia,
M. Pozzo,
M. Roveroni,
...
V. Bianco,
A. R. Luc,
A. Giuliani,
E. Diaco,
G. Naldini,
M. Trompetto,
R. Perinotti,
G. Sammarco
|
|
4 |
2022 |
Social Media Posts